Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds RSS Feed PharmiWeb Candidate Blog RSS Feed PharmiWeb Client Blog


Press Release

Aclaris Therapeutics to Attend Upcoming Investor Conferences

Posted on: 22 Nov 16

MALVERN, Pa., Feb. 06, 2017 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ:ACRS), a clinical-stage pharmaceutical company, today announced that members of its management team will present and host investor meetings at the following upcoming investor events:

Dr. Neal Walker, President and Chief Executive Officer, will present at LEERINK Partners 6th Annual Global Healthcare Conference in New York, NY on Wednesday, February 15, 2017, at 10:30 AM EST at the Lotte New York Palace Hotel in New York. 

Dr. Walker will also present at the Cowen and Company 37th Annual Healthcare Conference in Boston, MA on Tuesday, March 7, 2017 at 11:20 AM EST at the Boston Marriott Copley Place in Boston.

A live webcast of the presentations will be available on the Events and Webcasts section of the Company's website,  A replay will also be available after the event.

About Aclaris Therapeutics, Inc.
Aclaris Therapeutics, Inc. is a clinical-stage dermatologist-led pharmaceutical company focused on identifying, developing and commercializing innovative and differentiated therapies to address significant unmet needs in medical and aesthetic dermatology.  Aclaris is based in Malvern, Pennsylvania and more information can be found by visiting the Aclaris website at


Last updated on: 07/02/2017

Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.